MU
39
5
AKAM
54
3
CFG
58
6
IR
61
6
LB
45
15
CTAS
53
3
DGX
36
3
CSX
57
4
O
33
-4
V
56
2
RL
72
3
GLW
48
2
RCL
81
4
HSIC
36
-9
DOV
61
4
SYY
45
2
BRK.B
27
2
BA
48
-5
L
51
5
RIG
58
3
MU
39
5
AKAM
54
3
CFG
58
6
IR
61
6
LB
45
15
CTAS
53
3
DGX
36
3
CSX
57
4
O
33
-4
V
56
2
RL
72
3
GLW
48
2
RCL
81
4
HSIC
36
-9
DOV
61
4
SYY
45
2
BRK.B
27
2
BA
48
-5
L
51
5
RIG
58
3
Financhill
Back

NV5 Global 10K Form

Sell
23

NVEE
NV5 Global

Last Price:
25.58
Seasonality Move:
5.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVEE News And Ratings

See the #1 stock for the next 7 days that we like better than NVEE

NVEE Financial Statistics

Sales & Book Value

Annual Sales: $861.74M
Cash Flow: $-16.54M
Price / Cash Flow: 51.51
Annual Sales: $12.32
Price / Book: 1.95

Profitability

EPS (TTM): 0.50750
Net Income (TTM): $31.57M
Gross Margin: $430.36M
Return on Equity: 4.09%
Return on Assets: 2.64%

NV5 Global Earnings Forecast

Key NV5 Global Financial Ratios

  • The Gross Profit Margin over the past 14 years for NVEE is 49.94%.
  • The Selling, General & Administrative Expenses for NVEE have been equal to 34.09% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 29.07% of Operating Income.
  • The Net Earning history of NVEE is 5.18% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 10 years.

NV5 Global Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Professional Services
Sector: Industrials
Current Symbol: NVEE
CUSIP: 62945V
Website: nv5.com

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 2.29
Quick Ratio: 2.14

Price-to-Earnings

Trailing P/E Ratio: 33.4
Forward P/E Ratio: 17.15

NVEE Technical Analysis vs Fundamental Analysis

Sell
23
NV5 Global (NVEE) is a Sell

Is NV5 Global a Buy or a Sell?

  • NV5 Global stock is rated a Sell
    The current NV5 Global [NVEE] share price is $24.05. The Score for NVEE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.